CRON Stock Analysis: Buy, Sell, or Hold?
CRON - Cronos Group Inc. Common Share
$2.86
0.00 (0.00%)
▲
5d:
+4.76%
30d:
+4.76%
90d:
+13.94%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.8/10
Get Alerted When CRON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CRON shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CRON shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: CRON is currently trading at $2.86, which is considered extended relative to its 30-day fair value range of $2.68 to $2.82. The stock's valuation (Forward PE: 19.4) is in line with its historical norms (21.4). Remarkably, the market is currently pricing in an annual earnings decline of 3.3% over the next few years. This pessimistic expectation contrasts with the company's recent 126.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CRON is in a strong uptrend. The price is approaching resistance at $2.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CRON has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRON is in a strong uptrend. The price is approaching resistance at $2.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CRON has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $2.50. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.68 -
$2.82
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding CRON? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 12.5% above Wall St target ($2.50)
Trading Range Analysis
30-Day Trading Range
$2.68 -
$2.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.62
Resistance Level
$2.94
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.36
Wall Street Target
$2.50
(-12.5%)
Revenue Growth (YoY)
40.1%
Earnings Growth (YoY)
126.8%
Profit Margin
-1.1%
Valuation Discount vs History
-3.3% cheaper
PE vs Historical
19.4 vs 21.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.3%
(market-implied from PE analysis)
1-Year Target
$2.77
(-3%)
2-Year Target
$2.67
(-7%)
3-Year Target
$2.59
(-10%)
3-Yr Target (if PE normalizes)
(PE: 19→21)
$2.86
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 12.5%)
$4.58
(+60%)
Base:
(SPY PE: 19.4, Growth: 12.5%)
$4.07
(+42%)
Bear:
(PE: 16.5, Growth: 12.5%)
$3.46
(+21%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.4 to 21.4
Stabilization Target:
$3.16
(+10.5%)
PE Expansion Potential:
+10.5%
Share & Embed Analysis
Last updated: July 03, 2026 5:42 PM ET
Data refreshes hourly during market hours. Next update: 6:42 PM
Data refreshes hourly during market hours. Next update: 6:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
Advanced CRON Option Strategies
Professional options setups generated by AI based on today's CRON price and gamma walls.
